Skip to main content
menu sluit menu
Home Home
Login
Main navigation
  • Library
  • Calendar
  • e-Learning
  • News
    • Veterinary News In this section you find veterinary news
    • Recent Additions All content that was recently added to the IVIS library
  • Get involved
    • Donate Support IVIS, make a donation today
    • Media kit Promote your e-learning & events on IVIS
    • Add your e-learning & events to the IVIS calendar
    • Publish on IVIS Publish your work with us
  • About
    • Mission Our Mission Statement
    • What we do More info about IVIS and what we do
    • Who we are More info about the IVIS team
    • Authors See list of all IVIS authors and editors
  • Contact
User tools menu
User tools menu
Main navigation
  • Library
  • Calendar
  • e-Learning
  • News
    • Veterinary News In this section you find veterinary news
    • Recent Additions All content that was recently added to the IVIS library
  • Get involved
    • Donate Support IVIS, make a donation today
    • Media kit Promote your e-learning & events on IVIS
    • Add your e-learning & events to the IVIS calendar
    • Publish on IVIS Publish your work with us
  • About
    • Mission Our Mission Statement
    • What we do More info about IVIS and what we do
    • Who we are More info about the IVIS team
    • Authors See list of all IVIS authors and editors
  • Contact
Follow IVIS
  • Twitter
  • Facebook
Support IVIS

Breadcrumb

  1. Home
  2. Library
  3. Encyclopedia of Canine Clinical Nutrition
  4. Causes of Hyperlipidemia
Encyclopedia of Canine Clinical Nutrition
Back to Table of Contents
Add to My Library
Close
Would you like to add this to your library?

Get access to all handy features included in the IVIS website

  • Get unlimited access to books, proceedings and journals.
  • Get access to a global catalogue of meetings, on-site and online courses, webinars and educational videos.
  • Bookmark your favorite articles in My Library for future reading.
  • Save future meetings and courses in My Calendar and My e-Learning.
  • Ask authors questions and read what others have to say.
Sign in Register
Comments
Print this article
Share:
  • Facebook
  • LinkedIn
  • Mail
  • Twitter

Causes of Hyperlipidemia

Author(s):
Schenck P.A.
In: Encyclopedia of Canine Clinical Nutrition by Pibot P. et al.
Updated:
APR 21, 2008
Languages:
  • DE
  • EN
  • ES
  • FR
  • IT
Back to Table of Contents
Add to My Library
Close
Would you like to add this to your library?

Get access to all handy features included in the IVIS website

  • Get unlimited access to books, proceedings and journals.
  • Get access to a global catalogue of meetings, on-site and online courses, webinars and educational videos.
  • Bookmark your favorite articles in My Library for future reading.
  • Save future meetings and courses in My Calendar and My e-Learning.
  • Ask authors questions and read what others have to say.
Sign in Register
Print this article
SHARE:
  • Facebook
  • LinkedIn
  • Mail
  • Twitter
    Read

    3. Causes of Hyperlipidemia

    Hyperlipidemia may be the result of lipid abnormalities secondary to a number of other conditions (Table 3). Conditions resulting in secondary hyperlipidemia include hypothyroidism, pancreatitis, cholestasis, hyperadrenocorticism, diabetes mellitus, nephrotic syndrome, obesity, and the feeding of very high fat diets. These conditions should be investigated and eliminated as potential causes of the hyperlipidemia before primary hyperlipidemia is considered.

    Table 3. Causes of Hyperlipidemia in the Dog

    Postprandial

    Primary

    Idiopathic hyperlipoproteinemia

    Idiopathic hypercholesterolemia

    Idiopathic hyperchylomicronemia

    Secondary

    Hypothyroidism

    Diabetes Mellitus

    Pancreatitis

    Cholestasis

    Nephrotic Syndrome

    Hyperadrenocorticism

    High Fat Diets

    Obesity

    Hypothyroidism

    Hypothyroidism is the most common endocrine disease in dogs and often causes serum hyperlipidemia. In a survey of 2007 dogs with reported recurrent hyperlipidemia, 413 (21%) were diagnosed with hypothyroidism. Dogs with fasting hyperlipidemia were 3.2 times more likely to have hypothyroidism than dogs that did not have hyperlipidemia (Schenck, 2004).

    Increases in both serum cholesterol and triglyceride concentrations have been associated with canine hypothyroidism (Rogers et al., 1975b; Boretti et al., 2003). In one study of 50 dogs with hypothyroidism, 88% exhibited hypertriglyceridemia and 78% had hypercholesterolemia (Dixon et al., 1999). Congenital hypothyroidism resulted in hypercholesterolemia in 4 out of 5 Giant Schnauzers (Greco et al., 1991). Cholesterol elevations are usually moderate (Jaggy et al., 1994), and with adequate treatment of hypothyroidism, both cholesterol and triglyceride concentrations return to normal (Rogers et al., 1975b; Cortese et al., 1997). In dogs with hypercholesterolemia and hypertriglyceridemia associated with hypothyroidism, there are increases in VLDL, LDL and HDL1 (Mahley et al., 1974b; Rogers et al., 1975b), and the lipoprotein electrophoresis pattern should return to normal with thyroid replacement therapy. Cholesterol accumulation is seen in VLDL, and these cholesterol-rich particles may stimulate cholesteryl ester synthesis within tissue macrophages (Mahley et al., 1980).

    In humans with hypothyroidism, mRNA for LDL receptors is decreased resulting in decreased cholesterol and chylomicron clearance (Kovanen, 1987). Lipoprotein lipase activity may be increased (Hansson et al., 1983), diminished (Pykalisto et al., 1976) or unaltered (Franco et al., 2003), and there is decreased excretion of cholesterol into bile (Gebhard et al., 1992). Cholesterol synthesis is also decreased, but the decrease in clearance is greater than the decrease in synthesis, leading to a net increase in cholesterol concentration (Field et al., 1986).

    Pancreatitis

    Pancreatitis usually results in hyperlipidemia with an increase in both serum cholesterol and triglyceride concentrations, but the lipoprotein electrophoresis pattern remains normal until 48 to 72 hours post-induction of pancreatitis (Whitney et al., 1987). Free fatty acids and β-migrating lipoproteins (VLDL and LDL) increase (Rogers et al., 1975b; Whitney et al., 1987; Chikamune et al., 1998), and there is a consistent decrease in α1-migrating lipoprotein (HDL2) (Bass et al., 1976; Whitney et al., 1987). Changes in α2-migrating lipoproteins (HDL1) are inconsistent, and may be increased or decreased (Whitney et al., 1987). In addition, there may be other differences in the lipoprotein electrophoresis pattern depending on whether the pancreatitis is naturally occurring or experimentally induced.

    Within the lipoprotein structure, there are changes in lipid and protein content in pancreatitis. LDL exhibits an increase in triglyceride, total cholesterol, and phospholipid, and an increase of apoprotein B100 (Chikamune et al., 1998). VLDL shows an increase in total cholesterol and phospholipid. HDL particles have decreased total cholesterol and phospholipid, with an increase in apoprotein A-IV and a decrease in apoprotein A-I (Chikamune et al., 1998).

    11 year old Labrador bitch with hypothyroidism
    11 year old Labrador bitch with hypothyroidism (only clinical sign: obesity). (© L. Martin).

    Naturally occurring atherosclerosis has been noted in dogs with hypothyroidism
    Naturally occurring atherosclerosis has been noted in dogs with hypothyroidism. In a family of Beagles with hypothyroidism, there was evidence of moderate to severe atherosclerosis which occurred mainly in the coronary and renal arteries (
    Manning, 1979). Arteries were stenotic but patent, with no evidence of prior occlusion. Even with therapy for hypothyroidism, no regression of atherosclerotic plaques was seen despite a decrease in serum cholesterol concentration (DePalma et al., 1977). (© Lenfant).

    In humans, there is evidence that pancreatitis is associated with decreased lipoprotein lipase activity (Hazzard et al., 1984). This decreased activity of lipoprotein lipase may result in increased triglyceride concentrations with slower clearance of chylomicrons. Two dogs with pancreatitis also exhibited a moderate decrease in lipoprotein lipase activity, which returned to normal with treatment and resolution of the pancreatitis (Schenck, unpublished observations).

    Diabetes Mellitus

    In diabetes mellitus, elevations of both serum triglyceride and cholesterol concentration are typically observed (Rogers et al., 1975b; Renauld et al., 1998) (Table 4).

    Table 4. Modifications of Lipoprotein Electrophoresis in Diabetes Mellitus

    Increased lipoproteins
    - β-migrating lipoproteins, mostly due to an increase in VLDL (Whitney et al., 1993)
    - α2-migrating lipoprotein
    - Apoprotein E (
    Gleeson et al., 1990)
    - Chylomicrons (
    Whitney et al., 1993)

    Decreased lipoproteins
    - α1-migrating lipoproteins (HDL2) (Wilson et al., 1986)

    Cholesterol concentration increases in VLDL and IDL, and decreases in HDL (Wilson et al., 1986). Insulin therapy will usually decrease serum triglyceride concentration, but serum cholesterol concentration may remain elevated due to increased cholesterol synthesis (Gleeson et al., 1990) (Figure 8).

    In humans with diabetes mellitus, lipoprotein lipase activity is decreased, with an increase in free fatty acids (Steiner et al., 1975) and hepatic lipase activity (Muller et al., 1985). Urinary mevalonate concentration is elevated approximately 6-fold, indicating an increase in whole-body cholesterol synthesis, and HMGCoA reductase activity is increased (Kwong et al., 1991; Feingold et al., 1994). Intestinal cholesterol absorption may also be increased in diabetes mellitus (Kwong et al., 1991; Gylling et al., 1996). There is impaired removal of VLDL from the circulation (Wilson et al., 1986), and a decrease in the number and affinity of LDL receptors (Takeuchi, 1991). Prolonged retention of lipoprotein remnants may contribute to an increased delivery of cholesterol to extrahepatic tissues, and the increased concentration of HDL1 reflects a disturbance in cholesterol transport from peripheral cells back to the liver (Wilson et al., 1986).

    Naturally occurring atherosclerosis has been observed at necropsy in a dog with diabetes mellitus (Sottiaux, 1999). Atherosclerotic plaques were noted in the terminal aorta, coronary arteries, renal arteries, and arteries of the brain, but there was no evidence of thrombosis or complete occlusion of any vessel.

    Nephrotic Syndrome

    Lipoprotein abnormalities have been poorly characterized in dogs with nephrotic syndrome. Dogs with nephrotic syndrome show a mild increase in serum cholesterol concentration early in the course of disease, with a mild elevation of serum triglyceride concentration occurring later. Dogs with secondary hyperparathyroidism due to chronic renal failure exhibit a decrease in lipoprotein lipase activity, resulting in impaired removal of lipid from the circulation (Akmal et al., 1990).

    Lipoprotein abnormalities in nephrotic syndrome and chronic renal disease have been well characterized in humans, and the progression of renal dysfunction has been shown to correlate with serum total cholesterol (Washio et al., 1996). Lipoprotein lipase activity is decreased which may account for the hypertriglyceridemia due to a decrease in lipoprotein clearance (Olbricht, 1991). There is decreased clearance of LDL (Shapiro, 1991; Vaziri et al., 1996) due to decreased LDL receptor expression (Portman et al., 1992). LDL may also be increased due to an increase in synthesis (de Sain-van der Velden et al., 1998). HMGCoA reductase activity is increased in the liver (Szolkiewicz et al., 2002; Chmielewski et al., 2003), and the increased cholesterol does not up-regulate LDL receptors (Liang et al., 1997). Reverse cholesterol transport is impaired (Kes et al., 2002), and ACAT activity within the liver is increased with a decrease in LCAT activity (Liang et al., 2002).

    VLDL increases due to decreased catabolism (de Sain-van der Velden et al., 1998), and proteinuria may also stimulate VLDL synthesis by the liver, induced by hypoalbuminemia (D'Amico, 1991). Impaired clearance of VLDL may be due to deficiencies in apoprotein C-II, apoprotein C-III, and apoprotein E, creating smaller VLDL particles that are not cleared efficiently by receptors (Deighan et al., 2000). This altered structure of VLDL results in altered binding to endothelial bound lipoprotein lipase (Shearer et al., 2001), and proteinuria may also be associated with the urinary loss of heparan sulfate, an important cofactor for lipoprotein lipase (Kaysen et al., 1986). Synthesis of apoprotein A-I by the liver increases in response to proteinuria (Marsh, 1996), and protein catabolism in peripheral tissues is increased.

    Hyperadrenocorticism

    In hyperadrenocorticism, mild elevations of both serum cholesterol and triglyceride may be seen in dogs and humans (Friedman et al., 1996). Lipoprotein lipase activity is decreased with an increase in hepatic lipase activity (Berg et al., 1990). In addition, hypercortisolism stimulates production of VLDL by the liver (Taskinen et al., 1983). Excess glucocorticoids stimulate lipolysis, and this excess fat breakdown exceeds the liver's capacity for clearance. The occurrence of steroid hepatopathy in hyperadrenocorticism may lead to biliary stasis resulting in further lipid abnormalities.

    In hyperadrenocorticism, mild elevations of both serum cholesterol and triglyceride may be seen (Ling et al., 1979; Reusch et al., 1991). In dogs, concentration of β-migrating lipoproteins (VLDL and LDL) are typically increased (Bilzer, 1991).

    Cholestasis

    In cholestasis, there is typically moderate hypercholesterolemia, and there may be a mild hypertriglyceridemia (Chuang et al., 1995). Concentration of LDL increases, and HDL1 concentration decreases (Danielsson et al., 1977). In LDL, phospholipid content increases and triglyceride concentration decreases, but there is no change in composition of HDL. Both plasma cholesteryl ester and LCAT activity increases (Blomhoff et al., 1978).

    Obesity

    Some obese dogs show an increase in serum triglyceride concentration (Bailhache et al., 2003), and a mild increase in serum cholesterol (Chikamune et al., 1995). Free fatty acids are increased, triglyceride concentration is increased in both VLDL and HDL, and HDL cholesterol may be decreased (Bailhache et al., 2003). Phospholipid concentration is increased in both VLDL and LDL, and is decreased in HDL2 (Chikamune et al., 1995). There is a moderate decrease in lipoprotein lipase activity in some obese dogs, and activity increases with weight loss (Schenck, unpublished observation). Lipid abnormalities observed in obese dogs may however be secondary to insulin resistance (Bailhache et al., 2003).

    English Bulldog. Obesity may result in hyperlipidemia in a small percentage of dogs
    English Bulldog. Obesity may result in hyperlipidemia in a small percentage of dogs. (© M. Diez).

    High Fat Diets

    The feeding of high fat diets may result in hyperlipidemia and moderate elevation in serum cholesterol concentration. As serum cholesterol concentration increases, the majority of cholesterol is carried by HDLc (HDL1); thus an increase in α2-migrating lipoprotein is observed (Mahley et al., 1974b). A substantial portion of the HDL observed in response to cholesterol feeding is formed in the periphery (Sloop et al., 1983). Once this HDL reaches the plasma, it is converted to HDLc via the action of LCAT, which exhibits increased activity (Bauer, 2003). LDL and IDL concentrations increase, and the concentration of HDL2 decreases. Hypercholesterolemia results in the appearance of α-migrating VLDL, and cholesterol-enrichment also occurs in LDL, IDL and HDLc (Mahley et al., 1974b). Diets very high in fats (above 50%) may additionally cause an elevation in triglyceride (Reynolds et al., 1994) with a marked increase in circulating LDL and other abnormalities.

    Back to Table of Contents
    Add to My Library
    Close
    Would you like to add this to your library?

    Get access to all handy features included in the IVIS website

    • Get unlimited access to books, proceedings and journals.
    • Get access to a global catalogue of meetings, on-site and online courses, webinars and educational videos.
    • Bookmark your favorite articles in My Library for future reading.
    • Save future meetings and courses in My Calendar and My e-Learning.
    • Ask authors questions and read what others have to say.
    Sign in Register
    Print this article
    References

    1. Adan Y, Shibata K, Sato M et al. Effects of docosahexaenoic and eicosapentaenoic acid on lipid metabolism, eicosanoid production, platelet aggregation and atherosclerosis in hypercholesterolemic rats. Biosci Biotechnol Biochem 1999; 63(1):111-9.

    ...
    Show all
    Comments (0)

    Ask the author

    0 comments
    Submit
    Close
    Would to like to further discuss this item?

    Get access to all handy features included in the IVIS website

    • Get unlimited access to books, proceedings and journals.
    • Get access to a global catalogue of meetings, on-site and online courses, webinars and educational videos.
    • Bookmark your favorite articles in My Library for future reading.
    • Save future meetings and courses in My Calendar and My e-Learning.
    • Ask authors questions and read what others have to say.
    Sign in Register
    About

    How to reference this publication (Harvard system)?

    Schenck, P. A. (2008) “Causes of Hyperlipidemia”, Encyclopedia of Canine Clinical Nutrition. Available at: https://www.ivis.org/library/encyclopedia-of-canine-clinical-nutrition/causes-of-hyperlipidemia (Accessed: 31 January 2023).

    Affiliation of the authors at the time of publication

    College of Veterinary Medicine, Michigan State University, MI, USA.

    Author(s)

    • Schenck P.A.

      DVM MA PhD
      Department of Pathobiology and Diagnostic Investigation, College of Veterinary Medicine, Michigan State University
      Read more about this author

    Copyright Statement

    © All text and images in this publication are copyright protected and cannot be reproduced or copied in any way.
    Related Content

    Readers also viewed these publications

    • Journal Issue

      Veterinary Evidence - Vol 8 N°1, Jan-Mar 2023

      In: Veterinary Evidence
      JAN 28, 2023
    • Journal Issue

      Veterinary Evidence - Vol 7 N°4, Oct-Dec 2022

      In: Veterinary Evidence
      JAN 16, 2023
    • Proceeding

      SFT - Theriogenology Annual Conference - Bellevue, 2022

      By: Society for Theriogenology
      JAN 10, 2023
    • Journal Issue

      Urgencias y cuidados intensivos - Argos N°244, Diciembre 2022

      In: Argos
      DEC 31, 2022
    • Proceeding

      ISCFR-EVSSAR Symposium - Italy 2022

      By: International Symposium on Canine and Feline Reproduction
      DEC 02, 2022
    • Journal Issue

      Patología endocrina - Argos N°243, Noviembre 2022

      In: Argos
      NOV 27, 2022
    • Journal Issue

      Traumatología y neurología - Argos Nº242, Octubre 2022

      In: Argos
      NOV 10, 2022
    • Chapter

      Tibia and Tarsus

      In: Current Techniques in Small Animal Surgery (5th Edition)
      NOV 07, 2022
    • Chapter

      Femur and Stifle Joint

      In: Current Techniques in Small Animal Surgery (5th Edition)
      OCT 28, 2022
    • Journal Issue

      Medicina felina - Argos Nº241, Septiembre 2022

      In: Argos
      OCT 24, 2022
    • Chapter

      Sacroiliac Joint, Pelvis, and Hip Joint

      In: Current Techniques in Small Animal Surgery (5th Edition)
      OCT 17, 2022
    • Journal Issue

      Veterinary Evidence - Vol 7 N°2, Apr-Jun 2022

      In: Veterinary Evidence
      OCT 07, 2022
    • Journal Issue

      Veterinary Evidence - Vol 7 N°3, Jul-Sep 2022

      In: Veterinary Evidence
      OCT 04, 2022
    • Chapter

      Amputation of the Forelimb

      In: Current Techniques in Small Animal Surgery (5th Edition)
      OCT 02, 2022
    • Journal Issue

      Israel Journal of Veterinary Medicine - Vol. 77(3), Sep. 2022

      In: Israel Journal of Veterinary Medicine
      SEP 30, 2022
    • Chapter

      Carpus, Metacarpus, and Phalanges

      In: Current Techniques in Small Animal Surgery (5th Edition)
      SEP 26, 2022
    • Chapter

      Radius and Ulna

      In: Current Techniques in Small Animal Surgery (5th Edition)
      SEP 16, 2022
    • Chapter

      Humerus and Elbow Joint

      In: Current Techniques in Small Animal Surgery (5th Edition)
      SEP 10, 2022
    • Chapter

      Scapula and Shoulder Joint

      In: Current Techniques in Small Animal Surgery (5th Edition)
      SEP 05, 2022
    • Chapter

      Bone Grafts and Implants

      In: Current Techniques in Small Animal Surgery (5th Edition)
      SEP 03, 2022
    • Chapter

      External Skeletal Fixation

      In: Current Techniques in Small Animal Surgery (5th Edition)
      AUG 28, 2022
    • Chapter

      Plate-Rod Fixation

      In: Current Techniques in Small Animal Surgery (5th Edition)
      AUG 18, 2022
    • Chapter

      Fixation with Screws and Bone Plates

      In: Current Techniques in Small Animal Surgery (5th Edition)
      AUG 15, 2022
    • Journal Issue

      Israel Journal of Veterinary Medicine - Vol. 77(2), Jun. 2022

      In: Israel Journal of Veterinary Medicine
      AUG 12, 2022
    • Chapter

      Interlocking Nailing of Canine and Feline Fractures

      In: Current Techniques in Small Animal Surgery (5th Edition)
      AUG 11, 2022
    • Load more
    Back To Top
    Become a member of IVIS and get access to all our resources
    Create an account
    Sign in
    Leading the way in providing veterinary information
    About IVIS
    • Mission
    • What we do
    • Who we are
    Need help?
    • Contact
    Follow IVIS
    • Twitter
    • Facebook
    International Veterinary Information Service (IVIS) is a not-for-profit organization established to provide information to veterinarians, veterinary students, technicians and animal health professionals worldwide using Internet technology.
    Support IVIS
    © 2023 International Veterinary Information Service
    • Disclaimer
    • Privacy Policy